Progress of Auto-HSCT for Treatment of DLBCL--Review

Xi Wang, Bing Xia, Yi Zhuo Zhang

    Research output: Contribution to journalReview article

    Abstract

    Diffuse large B cell lymphoma(DLBCL)is the most common non-Hodgkin's lymphoma in adults,accounting for 30%-40% of non-Hodgkin's lymphoma in adults. The treatments of this lymphoma mainly include chemotherapy,radiotherapy and autologous hematopoietic stem cell transplantation. A large amount of studies show that autologous hematopoietic stem cell transplantation considered as the main treatmant approach can be used for primary high-risk young and relapsed or refractory DLBCL patients. Many scholars have evaluated the effectiveness of autologous hematopoietic stem cell transplantation for primarily high-risk young and relapsed or refractory DLBCL patients,and tried to improve the effectiveness of transplantation that showed some advantagcs for DLBCL patients.

    Original languageEnglish (US)
    Pages (from-to)1841-1846
    Number of pages6
    JournalZhongguo shi yan xue ye xue za zhi
    Volume26
    Issue number6
    DOIs
    StatePublished - Dec 1 2018

    ASJC Scopus subject areas

    • Medicine(all)

    Fingerprint Dive into the research topics of 'Progress of Auto-HSCT for Treatment of DLBCL--Review'. Together they form a unique fingerprint.

  • Cite this